Ibogaine reduces preference for cocaine consumption in C57BL/6By mice.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0091-3057(94)90105-8PMID 8115413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for cocaine dependence in monkeys following a prolonged period of exposure

  2004cited by this paper
• Ibogaine antagonizes cocaine-induced locomotor stimulation in mice.

  1992cited by this paper
• Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine.

  1992cited by this paper
• The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.

  1992cited by this paper
• Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

  1992cited by this paper
• Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.

  1992cited by this paper
• Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

  1992cited by this paper
• Cocaine actions, brain levels and receptors in selected lines of mice.

  1991cited by this paper
• Establishment of chronic intravenous drug self-administration in the C57BL/6J mouse.

  1991cited by this paper
• Orally delivered cocaine functions as a positive reinforcer in C57BL/6J mice.

  1991cited by this paper
• Ritanserin, a new therapeutic approach for drug abuse. Part 1: Effects on alcohol

  1991cited by this paper
• Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.

  1990cited by this paper
• Extracellular Concentrations of Cocaine and Dopamine Are Enhanced During Chronic Cocaine Administration

  1990cited by this paper
• Genetic approaches to the analysis of addiction processes.

  1989cited by this paper
• Persistent augmented dopamine release after acute cocaine requires dopamine receptor activation.

  1989cited by this paper
• Sensitization to cocaine in the nigrostriatal dopamine system.

  1988cited by this paper
• Effects of Daily Cocaine and Morphine Treatment on Somatodendritic and Terminal Field Dopamine Release

  1988cited by this paper
• Psychomotor stimulant vs. local anesthetic effects of cocaine: role of behavioral sensitization and kindling.

  1988cited by this paper
• Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice.

  1987cited by this paper
• Cocaine withdrawal produces behavioral disruptions in rats.

  1987cited by this paper
• Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens.

  1987cited by this paper
• Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice.

  1987cited by this paper
• Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

  1986cited by this paper
• Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin.

  1981cited by this paper
• Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis.

  1981cited by this paper
• Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis.

  1981cited by this paper
• Oral vs parenteral drug effects on schedule-controlled behavior in rhesus monkeys.

  1980cited by this paper
• Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines.

  1978cited by this paper
• Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.

  1977cited by this paper
• Behavioral Effects of Cocaine--Metabolic and Neurochemical Approach

  1977cited by this paper
• Cocaine: Distribution and Metabolism in Animals

  1977cited by this paper

• Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders

  2023cites this paper
• Neural circuits controlling choice behavior in opioid addiction.

  2022cites this paper
• Tabernaemontana divaricata: A Herbal Panacea

  2022cites this paper
• Traditional treatment strategies for alcoholism and the withdrawal symptoms

  2021cites this paper
• Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

  2018cites this paper
• EL POTENCIAL TERAPEUTICO DE LOS ALUCINOGENOS EN EL TRATAMIENTO DE LAS ADICCIONES

  2017cites this paper
• Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms. II. Treatment Strategies

  2017cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• ibogaine in the treatment of chemical dependence disorders: clinical perspectives

  2016cites this paper
• Ibogaine in the treatment of substance dependence.

  2013cites this paper
• Green tea extract co-administered with a polymer effectively prevents alcoholic liver damage by prolonged inhibition of alcohol absorption in mice.

  2013cites this paper
• Fatalities Temporally Associated with the Ingestion of Ibogaine

  2012cites this paper
• Noribogaine, but Not 18-mc, Exhibits Similar Actions as Ibogaine on Gdnf Expression and Ethanol Self-administration Introduction

  2012cites this paper
• Sigma receptors and cocaine abuse.

  2011cites this paper
• Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration

  2010cites this paper
• Traditional Medicine in the Treatment of Drug Addiction

  2009cites this paper
• ALTERNATIVE HEALTH PRACTICES IN ADDICTION TREATMENT

  2009cites this paper
• Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review

  2008cites this paper
• Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review

  2008cites this paper
• Ethnobotany & ethnopharmacology of Tabernaemontana divaricata.

  2008cites this paper
• Glial Cell Line-derived Neurotrophic Factor Reverses Ethanol-mediated Increases in Tyrosine Hydroxylase Immunoreactivity via Altering the Activity of Heat Shock Protein 90*

  2008cites this paper
• Neurochemical Adaptations and Cocaine Dependence

  2007cites this paper
• Ibogaine and Noribogaine: Comparing Parent Compound to Metabolite

  2006cites this paper
• GDNF and Addiction

  2005cites this paper
• Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine against Alcohol Consumption

  2005cites this paper
• GlialCellLine-DerivedNeurotrophicFactorMediatesthe DesirableActionsoftheAnti-AddictionDrugIbogaine againstAlcoholConsumption

  2005cites this paper
• Ibogaino vartojimas toksikomanijoms gydyti Neurocheminis ir farmakologinis veikimas

  2004cites this paper
• lbogaine and Cocaine Abuse : Pharmacological Interactions at Dopamine and Serotonin Receptors

  2003cites this paper
• Plants and the central nervous system.

  2003cites this paper
• Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.

  2003cites this paper
• Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19.

  2002cites this paper
• OF 18-METHOXYCORONARIDINE , AN IBOGAINE ANALOG , TO 18-HYDROXYCORONARIDINE BY GENETICALLY VARIABLE CYP 2 C 19

  2002cites this paper
• Sigma receptors and iboga alkaloids.

  2001cites this paper
• Ibogaine neurotoxicity assessment: electrophysiological, neurochemical, and neurohistological methods.

  2001cites this paper
• Iboga interactions with psychomotor stimulants: panacea in the paradox?

  2001cites this paper
• Changes in gene expression and signal transduction following ibogaine treatment.

  2001cites this paper
• Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties.

  2001cites this paper
• Modulation of the effects of rewarding drugs by ibogaine.

  2001cites this paper
• Ibogaine: a review.

  2001cites this paper
• Case studies of ibogaine treatment: implications for patient management strategies.

  2001cites this paper
• Long-Lasting Ibogaine Protection against NMDA-Induced Convulsions in Mice

  2000cites this paper
• Application of Electrophysiological Method to Study Interactions between Ibogaine and Cocaine

  2000cites this paper
• Potential use of medicinal plants in the treatment of alcoholism.

  2000cites this paper
• 18‐Methoxycoronaridine (18‐MC) and Ibogaine: Comparison of Antiaddictive Efficacy, Toxicity, and Mechanisms of Action

  2000cites this paper
• Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.

  1999cites this paper
• Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice.

  1999cites this paper
• Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats

  1999cites this paper
• Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.

  1999cites this paper
• Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice

  1999cites this paper
• Chapter 3 - Pharmacology of Ibogaine and Ibogaine-Related Alkaloids

  1999cites this paper
• Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.

  1999cites this paper
• Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain.

  1999cites this paper
• Establishing orally self-administered cocaine as a reinforcer in rats using home-cage pre-exposure.

  1998cites this paper
• Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.

  1998cites this paper
• Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.

  1998cites this paper
• In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocaine a

  1998cites this paper
• In vivo ibogaine blockade and in vitro PKC action of cocaine.

  1998cites this paper
• Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence a

  1998cites this paper
• Behavioral Pharmacology of Hallucinogens

  1998cites this paper
• Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.

  1998cites this paper
• Ibogaine interferes with the establishment of amphetamine place preference learning.

  1997cites this paper
• Neurochemistry of Drug Abuse

  1997cites this paper
• Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats.

  1997cites this paper
• Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.

  1997cites this paper
• Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors.

  1996cites this paper
• Effects of ibogaine and noribogaine on phosphoinositide hydrolysis.

  1996cites this paper
• 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.

  1996cites this paper
• Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine

  1996cites this paper
• Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors.

  1996cites this paper
• The effect of ibogaine on Sigma- and NMDA-receptor-mediated release of [3H]dopamine.

  1996cites this paper
• Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum.

  1996cites this paper
• Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference.

  1996cites this paper
• Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, Cerebellum

  1996cites this paper
• The Use of Hallucinogens in the Treatment of Addiction

  1996cites this paper
• Ibogaine attenuates morphine-induced conditioned place preference.

  1995cites this paper
• Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry.

  1995cites this paper
• 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

  1995cites this paper
• Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats.

  1995cites this paper
• High affinity ibogaine binding to a mu opioid agonist site.

  1995cites this paper
• NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

  1995cites this paper
• Ibogaine possesses a selective affinity for sigma 2 receptors.

  1995cites this paper
• Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

  1995cites this paper
• Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.

  1995cites this paper
• The effect of ibogaine on κ-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6BY mice

  1995cites this paper
• Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.

  1995cites this paper
• Ibogaine possesses a selective affinity for σ2 receptors

  1995cites this paper
• Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats

  1994cites this paper
• The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

  1994cites this paper
• Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.

  1994cites this paper